← All claims

Diets · Metabolic & Cardiometabolic

intermittent fasting improves insulin sensitivity independent of weight loss

In plain terms: Does alternate-day / 5:2 fasting improve insulin sensitivity more than plain calorie-cutting at the same weight loss?

Contested Diets 🔬 Includes disconfirming

Part of: 🥗 intermittent fasting

RefutedContestedStrong support
consensus score -0.17

Mixed — one intermittent-energy-restriction RCT showed greater HOMA-IR improvement than daily restriction, but the largest year-long alternate-day-fasting trial found no insulin-sensitivity advantage, so a weight-independent effect is not established.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Human trials (RCT / n-of-1)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

2 support 4 contradict 1 tested null 4 mixed · 11 sources, 6 independent groups

The evidence (11)

SourceGradeStanceQualityFinding
Zhang
2025 · BMC Endocr Disord
meta-analysis mixed moderate Meta-analysis in metabolic syndrome found intermittent fasting improved some glucolipid measures, but benefits over continuous restriction were inconsistent when calorie intake was matched.
Harvie
2013 · Br J Nutr
RCT supports moderate In 115 overweight women, 2-day/week intermittent energy+carb restriction cut insulin resistance more than isocaloric daily restriction over 3 months, suggesting an effect partly beyond weight loss.
Rehman
2026 · J Nutr
RCT mixed moderate Secondary analysis of an early-TRE randomized trial found cardiometabolic effects varied by phenotype/age/sex/race, indicating any insulin-sensitivity benefit is not uniform.
Andriessen
2022 · Diabetologia
RCT contradicts high Three weeks of time-restricted eating improved glucose homeostasis but did NOT improve clamp-measured insulin sensitivity in type 2 diabetes, a well-powered null on the sensitivity endpoint.
Harvie M, et al.
2025 · BMC Nutr
RCT contradicts moderate Randomized trial matching intermittent to continuous energy restriction found improved fasting insulin resistance only immediately after fasting days, not maintained across the week, so no durable advantage.
Harvie
2011 · Int J Obes (Lond)
RCT mixed moderate Intermittent energy restriction produced insulin-sensitivity improvements broadly similar to continuous restriction, with only modest suggestion of added benefit, in young overweight women.
Trepanowski JF, et al. (Varady)
2017 · JAMA Intern Med
RCT contradicts high In a 1-year alternate-day-fasting RCT in metabolically healthy obese adults, fasting insulin and HOMA-IR did not improve versus daily calorie restriction despite comparable weight loss.
Castela
2022 · Clin Nutr
RCT mixed moderate Randomized controlled trial found intermittent energy restriction reduced adipose-tissue inflammation comparably to continuous restriction, without a clear insulin-sensitivity advantage.
Schroor
2024 · Adv Nutr
meta-analysis tested-null high Meta-analysis of 28 trials found intermittent energy restriction (ADF/5:2/TRE) produced cardiometabolic changes comparable to continuous restriction, with no clear weight-independent metabolic advantage.
Sutton EF, et al. (Peterson)
2018 · Cell Metab
RCT supports high Supervised weight-maintenance crossover trial found early time-restricted feeding improved insulin sensitivity and beta-cell responsiveness independent of weight loss in men with prediabetes.
Bonham
2025 · EBioMedicine
RCT contradicts moderate Three-arm randomized trial in night-shift workers found intermittent fasting produced weight loss but no superiority over continuous energy restriction for improving insulin resistance.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.